We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NVTA market cap is 171.9M. The company's latest EPS is USD -10.8425 and P/E is -0.06.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 133.54M | 122.45M | 117.36M | 120.53M | 121.24M |
| Operating Income | -206.75M | -225.45M | -125.02M | -145.62M | -99.02M |
| Net Income | -301.16M | -99.82M | -192.18M | -206.51M | -942.11M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 147.7M | 216.82M | 279.6M | 847.1M | 518.15M |
| Operating Income | -122.56M | -244.11M | -652.17M | -391.64M | -3.17B |
| Net Income | -129.36M | -241.97M | -602.17M | -379.01M | -3.11B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.03B | 1.95B | 1.69B | 1.52B | 535.12M |
| Total Liabilities | 1.87B | 1.85B | 1.73B | 1.72B | 1.62B |
| Total Equity | 158.87M | 101.84M | -36.66M | -200.79M | -1.08B |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 282.96M | 781.6M | 3.43B | 4.92B | 1.95B |
| Total Liabilities | 121.12M | 401.96M | 1.45B | 1.94B | 1.85B |
| Total Equity | 161.84M | 379.64M | 1.98B | 2.98B | 101.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -410.93M | -492.96M | -34.4M | -89.3M | -156.2M |
| Investing | -296.69M | -174.8M | 73.88M | 189.94M | 195.06M |
| Financing | 1.16M | 1.76M | -135.77M | -134.89M | -138.27M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -92.22M | -145.05M | -298.5M | -559.82M | -492.96M |
| Investing | 35.77M | -280.31M | -400.58M | -204.08M | -174.8M |
| Financing | 157.15M | 464.77M | 672.99M | 1.57B | 1.76M |
| Market Cap | 171.9M |
| Price to Earnings Ratio | -0.06 |
| Price to Sales Ratio | 0.33 |
| Price to Cash Ratio | 0.67 |
| Price to Book Ratio | 1.69 |
| Dividend Yield | - |
| Shares Outstanding | 286.49M |
| Average Volume (1 week) | 6.46M |
| Average Volume (1 Month) | 7.93M |
| 52 Week Change | -78.65% |
| 52 Week High | 2.94 |
| 52 Week Low | 0.36 |
| Spread (Intraday) | 0 (0.02%) |
| Company Name | Invitae Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.invitae.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
